Our findings demonstrate that QZD exerts its anti-tumor effects in high-risk locally advanced NPC primarily by inducing apoptosis and inhibiting the PI3K-Akt signaling pathway. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.